ypsomed news - Search News

Novo Nordisk, Ypsomed and CagriSema

Ypsomed will make injection pens for Novo Nordisk's CagriSema, says source

Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker's next-generation experimental obesity drug CagriSema, a source familiar with the matter has told Reuters.

Hosted on MSN · 1d

Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pens

Novo Nordisk’s (NVO) (OTCPK:NONOF) contract with Swiss medical device maker Ypsomed (OTCPK:YPHDF) includes a deal to supply injection pens for Danish drugmaker’s next-gen obesity therapy CagriSema, Reuters reported Friday, citing a source familiar with ...

GlobalData on MSN · 1d

“No magic wand” for Novo Nordisk, as CagriSema pen supply rumours swirl

Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Ypsomed Holding (VTX:YPSN) Is Looking To Continue Growing Its Returns On Capital

If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. To calculate this metric for Ypsomed Holding, this is the ...

pharmaphorum2y

Ypsomed brings Sidekick on board to fight self-injection anxiety

Now, a partnership between Ypsomed and Sidekick Heath aims to tackle that problem. Ypsomed is a top developer of injection and infusion systems, so knows a lot about the difficulties that patients ...

devdiscourse1d

FDA's Game-Changing Approvals and Global Health Alerts

The latest health news highlights FDA's approval of BridgeBio's drug for a rare heart condition, cancer features in healthy ...

Yahoo Finance21d

Ypsomed Holding (SWX:YPSN) Partners with Astria for STAR-0215 Autoinjector Amid Valuation Concerns

Ypsomed Holding (SWX:YPSN) has recently announced a strategic partnership with Astria Therapeutics to develop an autoinjector for STAR-0215, underscoring its commitment to innovation and enhancing ...

Nasdaq1mon

Becton Dickinson announces strategic collaboration with Ypsomed

Becton, Dickinson and Company announced a strategic collaboration with Ypsomed, a developer of injection systems, to advance self-injection solutions for high-viscosity biologic drugs.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results